Myo-Inositol vs D-Chiro-Inositol vs DC95

Three different names show up on inositol supplement labels — myo-inositol, D-chiro-inositol, and DC95. Only two of them are different molecules. The third isn't a molecule at all. And the gap between what those names look like and what they mean is where a lot of money gets spent on the wrong product.

If you've spent any time comparing inositol supplements, you've seen the labels blur together. One says "4000mg inositol." Another says "myo & D-chiro inositol, 40:1." A third lists "Myo Inositol DC 95%." They all sound roughly equivalent. They are not.

This article is the decoder. By the end, you'll be able to pick up any inositol product, read its ingredients panel, and know exactly what you're holding — which molecules, in what ratio, at what dose, and whether one of those official-looking abbreviations is doing something other than what you assumed. Same standard we hold ourselves to when we formulate Belle Balance: tell people what the label actually means, including the parts most brands would rather you skimmed.

The quick map: two molecules and one manufacturing format

Start here, because it resolves most of the confusion in a single table.

That bottom row is the one that costs people. A label reading "Myo Inositol DC 95%" is listing myo-inositol — once. If a buyer skims "DC" and reads "D-chiro," they believe they're getting two molecules when they're getting one. The rest of this article unpacks why each distinction is worth caring about.

Myo-inositol vs D-chiro-inositol: what's actually different

The two molecules are stereoisomers — same atoms, arranged slightly differently. That small structural difference gives them distinct roles in the body, and the body keeps them in a deliberate balance rather than treating them as interchangeable.

Your body converts a portion of its myo-inositol into D-chiro-inositol using an insulin-dependent enzyme. In other words, D-chiro-inositol is downstream of myo-inositol, and how much gets made is governed by insulin signalling. The two forms then do different jobs: research summarised by Bizzarri and colleagues (2023) describes myo-inositol as the form predominantly involved in glucose uptake and follicle-stimulating-hormone signalling, while D-chiro-inositol is more involved in insulin-mediated glucose storage and androgen-related pathways.

This matters because different tissues want different ratios. The ovary, in particular, is a myo-inositol-rich environment, and that local balance appears to be part of how it functions normally. Flood a system built for mostly-myo with a large dose of D-chiro and you're not "adding more of a good thing" — you're shifting a ratio the body maintains for a reason. Which is exactly why the ratio, not just the presence of both forms, is the number that deserves your attention.

Why the 40:1 ratio matters (and why more D-chiro isn't better)

The figure that appears throughout the inositol research is 40:1 — forty parts myo-inositol to one part D-chiro-inositol. That's not a marketing number. It reflects the approximate ratio of the two forms found in the plasma of healthy women, and it's the ratio used in the formulations the supporting research is built on. A 2024 review by Lete and colleagues sets out the rationale for the 40:1 combination as the physiologically-aligned approach. We've written about this in more depth in why the 40:1 inositol ratio matters.

Here's the counterintuitive part. With most supplement ingredients, "more of the active" reads as "better value." With D-chiro-inositol, the opposite can be true. Published research has reported that supraphysiological doses of D-chiro-inositol — far above the natural ratio — can impair ovarian function, which is the opposite of what people reach for inositol hoping to support. This has been described in the literature as the "D-chiro-inositol paradox": a little is part of the natural picture, but a lot, in the wrong place, works against you.

So when you see a product boasting a high D-chiro content — a 10:1 or 5:1 ratio, or a big standalone D-chiro number — that's not a premium feature. The clinical literature doesn't support pushing D-chiro above the natural ratio for reproductive-age women, and there's a credible case it's counterproductive. The 40:1 ratio is conservative on purpose.

So what is DC95, really?

Now back to the abbreviation that started this. You'll find "DC95," "DC 95%," or "Myo Inositol DC 95%" listed on a number of UK inositol products — typically tablets. Decoded, it means: myo-inositol supplied at around 95% purity in a direct-compression grade, with the remaining ~5% being a carrier (commonly PVP, polyvinylpyrrolidone) that lets the powder bind and press cleanly into a tablet.

There is nothing wrong with DC95 as an ingredient. Direct-compression grades exist for a sensible reason — they make tablet manufacturing reliable. The issue isn't quality. The issue is interpretation.

DC95 is myo-inositol. Full stop. It is not D-chiro-inositol, and it does not add a second molecule to the formula. On a label, the abbreviation sits in the same visual space where you'd expect to see "D-chiro," and the "DC" prefix does the rest of the work on a tired, scrolling reader. The result is a product that contains one molecule of inositol being read as though it contains two.

You can confirm this for yourself on any label that uses it: where a product genuinely contains both forms, you'll see "Myo Inositol DC 95%" and, separately, "D-Chiro Inositol" listed as its own line. Two lines, two molecules. One line with "DC95" in it is one molecule — myo — in tablet-ready form. If a label shows only the DC95 line and no separate D-chiro entry, it is a myo-only product, regardless of how the abbreviation reads at a glance.

This is the kind of thing that's invisible until someone points it out, and obvious forever after. It's also a clean example of a broader truth about supplement labels: the information is usually all there. It's just arranged so that the busy version of you fills in the gaps with assumptions.

How to read an inositol label in under a minute

Four checks, in order. Once you've done it a couple of times it becomes automatic.

1. Find the total myo-inositol dose, per day. Not per tablet or per scoop — per daily serving. Look at the recommended number of tablets and multiply. The figure the research is built on is in the region of 4,000mg of myo-inositol daily. A front-of-pack "4000mg" that turns out to be spread across four tablets you have to remember to take is a different proposition from 4,000mg in a single daily serving.

2. Check whether D-chiro-inositol is present, and at what ratio. Look for a separate "D-chiro-inositol" line and a stated ratio. If you see "40:1," good. If you see a much higher D-chiro proportion, that's a flag, not a feature. If there's no D-chiro line at all, it's a myo-only product — legitimate, but a different format that shouldn't be priced or perceived as a dual-form product.

3. Don't mistake DC95 for D-chiro. If the label says "DC95" or "DC 95%," that's your myo-inositol in direct-compression grade. It is not a second molecule. Make sure any D-chiro you're paying for appears as its own separate entry.

4. Check the format and what comes with it. Inositol is needed in gram quantities, which is a lot of material to deliver. Tablets solve that with binders and compression aids; powders and sachets dissolve into water. Neither is "wrong," but the format determines how much carrier rides along — and how easy the daily dose is to actually take. A 4,000mg daily dose as four tablets is four tablets a day, every day. The same dose as a single sachet is one drink.

A word on dose: 2,000mg vs 4,000mg

Dose is where a lot of inositol products quietly fall short, so it's worth being precise. The inositol research base spans a range of daily doses — studies have used 1,000mg, 2,000mg and 4,000mg — which is part of why comparing across studies is genuinely difficult. But the dose used most consistently in the trials people cite sits at the top of that range. A large observational study by Regidor and Schindler (2016) used 2 × 2,000mg of myo-inositol daily — that is, 4,000mg total — and 4,000mg recurs throughout the controlled trials in this space.

What this means for label-reading: a product delivering 2,000mg of myo-inositol per day is delivering half of the most-studied dose. That's not necessarily useless — 2,000mg has its own smaller evidence base — but a buyer comparing a 2,000mg product and a 4,000mg product by the word "inositol" alone is comparing two different research realities. The number matters as much as the name. (We go deeper on this in what "clinical dose" actually means in supplements, and on the practical side — timing, splitting the dose, building a routine that lasts — in how to take inositol.)

Do you need any of this if you don't have PCOS?

This question comes up constantly, and it's a fair one — most inositol research has been conducted in women with PCOS, so it's easy to assume the ingredient is only "for" that.

The honest answer is that the research context and the everyday reason people reach for inositol aren't the same thing. The trials were run in women with PCOS because that's where the clearest hormonal and metabolic markers are to measure. But the molecules themselves are simply forms of inositol the body uses in insulin signalling and ovarian function — not a PCOS-specific drug. Plenty of women who feel hormonally out of rhythm — cycles that have drifted, the after-effects of coming off hormonal contraception, the depletion that comes with sustained stress, the early shifts of perimenopause — take an interest in inositol without a PCOS diagnosis anywhere in the picture.

What inositol is not is a weight-loss product, however it's sometimes marketed. We'd steer you firmly away from any inositol framed primarily around dropping weight; that's a claim the evidence doesn't cleanly support, and it's not why the ingredient earns its place. The reason to care about myo-inositol, the 40:1 ratio, and an honest dose is the same whether or not PCOS is part of your story: you want the form, ratio and dose the research actually used, rather than a label that shares their vocabulary and little else. And if you do have a diagnosis, or you're pregnant, breastfeeding, taking medication, or under medical care, the right move is always to talk it through with your GP or pharmacist before starting any supplement.

The label is an argument. Now you can read it.

Every inositol label is making a case for itself, and most of the case is in the parts people skim. The molecule names tell you what's in the tin. The ratio tells you whether the formula respects how the body actually uses these compounds. The dose tells you whether it reaches the research threshold or stops politely short of it. And a small abbreviation like DC95 tells you whether you're reading carefully or filling in blanks.

None of this requires a chemistry background. It requires knowing that "inositol" is not one thing, that the ratio is not a detail, that 4,000mg and 2,000mg are not the same offer, and that "DC" is not "D-chiro." That's the whole literacy. It takes a minute per label and it changes which products earn your money. The brands hoping you won't look this closely are counting on the names doing the work. Now the names work for you instead.

Frequently Asked Questions

What is the difference between myo-inositol and D-chiro-inositol?

Myo-inositol and D-chiro-inositol are two forms (stereoisomers) of inositol — the same atoms arranged differently. The body makes D-chiro-inositol from myo-inositol using an insulin-dependent enzyme, and the two forms play distinct roles in insulin signalling and ovarian function. Most inositol research is built on myo-inositol, with D-chiro-inositol included in a small, fixed proportion.

Is DC95 the same as D-chiro-inositol?

No. DC95 (or "DC 95%") is a direct-compression manufacturing grade of myo-inositol — typically around 95% myo-inositol with about 5% carrier such as PVP, designed to press cleanly into tablets. The "DC" stands for "direct compression", not "D-chiro". A product listing only "Myo Inositol DC 95%" contains one inositol molecule (myo); genuine dual-form products list "D-Chiro Inositol" as a separate ingredient.

What does the 40:1 inositol ratio mean?

The 40:1 ratio means forty parts myo-inositol to one part D-chiro-inositol. It reflects the approximate ratio of the two forms found in the plasma of healthy women and is the ratio used in the formulations the supporting research is built on. A 2024 review by Lete and colleagues sets out the rationale for this physiologically-aligned ratio.

Is myo-inositol or D-chiro-inositol better?

They aren't really competitors — research supports using them together at the 40:1 ratio rather than choosing one. Importantly, more D-chiro-inositol is not better: published research has reported that supraphysiological doses of D-chiro-inositol can impair ovarian function, so a high D-chiro proportion is a flag rather than a premium feature.

Can you take inositol if you don't have PCOS?

Most inositol research has been conducted in women with PCOS because that's where the clearest hormonal and metabolic markers are to measure, but the molecules are simply forms of inositol the body uses, not a PCOS-specific drug. Many women take an interest in inositol without a PCOS diagnosis. Inositol is not a weight-loss product, and any supplement framed that way is best approached with caution. If you have a diagnosis, are pregnant or breastfeeding, or take medication, speak to your GP or pharmacist first.

How much myo-inositol should you take per day?

The dose used most consistently in the trials cited for women's hormonal balance is around 4,000mg of myo-inositol daily, often split into two servings. The research base also includes 1,000mg and 2,000mg doses, so a 2,000mg product delivers roughly half the most-studied amount. Check the total myo-inositol per daily serving, not per tablet.

---